Chemoinformaics analysis of 2-(7-METHOXY-2-OXOCHROMEN-8-YL)-3-METHYLBUT-2-ENAL
| Molecular Weight | 258.273 | nRot | 3 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 14 |
| Exact Molecular Weight | 258.089 | nRing | 2 |
| Solubility: LogS | -3.676 | nHRing | 1 |
| Solubility: LogP | 2.136 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 37.5931 |
| nHD | 0 | BPOL | 19.2529 |
| QED | 0.482 |
| Synth | 2.811 |
| Natural Product Likeliness | 1.24 |
| NR-PPAR-gamma | 0.077 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.118 |
| HIA | 0.011 |
| CACO-2 | -4.749 |
| MDCK | 0.0000184 |
| BBB | 0.03 |
| PPB | 0.812272 |
| VDSS | 1.092 |
| FU | 0.12874 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.952 |
| CYP2c19-inh | 0.637 |
| CYP2c19-sub | 0.524 |
| CYP2c9-inh | 0.216 |
| CYP2c9-sub | 0.812 |
| CYP2d6-inh | 0.66 |
| CYP2d6-sub | 0.819 |
| CYP3a4-inh | 0.637 |
| CYP3a4-sub | 0.408 |
| CL | 9.012 |
| T12 | 0.616 |
| hERG | 0.009 |
| Ames | 0.696 |
| ROA | 0.085 |
| SkinSen | 0.392 |
| Carcinogencity | 0.894 |
| EI | 0.211 |
| Respiratory | 0.903 |
| NR-Aromatase | 0.435 |
| Antiviral | Yes |
| Prediction | 0.700458 |